Daily aspirin reduces colon cancer risk, study shows
Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.
When ‘Cancer’ Gets in the Way of Treatment
Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.
Hosted on MSN2d
Triple Therapy in Metastatic CRC With BRAF Mutations: The New Standard of Care?
First-line treatment with targeted therapies plus chemotherapy offered overall response benefits in BRAF V600E-mutant ...
Medpage Today on MSN2d
Combination Slows Metastatic CRC Progression Better Than Single Immunotherapy
An immunotherapy combination for advanced, highly mutated colorectal cancer (CRC) significantly slowed disease progression ...
Demand For Advanced Pancreatic Cancer Treatments At All Time High As Promising Options Come Into Focus - Financial News Media
In pancreatic cancer, pelareorep previously demonstrated a strong efficacy signal when administered with gemcitabine, nab-paclitaxel and atezolizumab. Our new safety data indicate its ability to also ...
Demand for Advanced Pancreatic Cancer Treatments at All Time High as Promising Options Come into Focus
The aging population and lifestyle-related factors contribute to a surge in pancreatic cancer cases. The aggressive nature of the disease and its high mortality rate demand innovative therapies.
grampianonline16d
GSK buys US-based rare cancer treatment developer for up to £1bn
The acquisition of IDRx will help GSK target a ‘major gap in the current standard of care’ related to gastrointestinal ...
heraldscotland16d
GSK buys US-based rare cancer treatment developer for up to £1bn
according to the American Cancer Society. GSK’s acquisition of IDRx will include IDRX-42 which is currently being developed and trialled as therapy for the treatment of gastrointestinal stomal ...